Caitong International Asset Management Co., LTD Collegium Pharmaceutical, Inc Transaction History
Caitong International Asset Management Co., LTD
- $144 Billion
- Q3 2025
A detailed history of Caitong International Asset Management Co., LTD transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 208 shares of COLL stock, worth $9,563. This represents 0.01% of its overall portfolio holdings.
Number of Shares
208
Previous 63
230.16%
Holding current value
$9,563
Previous $1.86 Million
290.66%
% of portfolio
0.01%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding COLL
# of Institutions
258Shares Held
37.6MCall Options Held
53.7KPut Options Held
200-
Black Rock Inc. New York, NY5.79MShares$266 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY2.83MShares$130 Million1.63% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.39MShares$110 Million1.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.23MShares$102 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.6MShares$73.5 Million0.08% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.57B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...